Impact of intra-/postoperative MRI on the clinical course of patients with operated brain metastases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021224

Enrollment

100

Registered

2020-12-14

Start date

2020-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79.3

Interventions

Group 1: Prospective observation: patients with brain metastasis who underwent surgical resection and received MR-based resection control. Observation period planned every 3 months for at least 1 year

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.) patients with brain metastasis 2.) surgical resection of the brain metastasis 3.) intraoperative or postoperative MR imaging with contrast agent

Exclusion criteria

Exclusion criteria: Contraindication for MRI

Design outcomes

Primary

Measure	Time frame
Frequency of residual tumor tissue in MR resection control	—

Secondary

Measure	Time frame
a) frequency of resection b) occurrence of a local recurrence during follow-up c) quantifying the general condition (Karnfsky performance scale) d) overall survival	—

Countries

Germany

Contacts

Public ContactTizian Rosenstock

Klinik für Neurochirurgie Charité - Universitätsmedizin Berlin

tizian.rosenstock@charite.de+4930450660394

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026